Investor Presentaiton slide image

Investor Presentaiton

2.Presence in key pockets of Value Chain Diagnostic Industry - Fragmented Technician Run Lab Pathologist Run Lab Hospital Run Lab Leading Diagnostics Chains at an advantage Years of experience, brand value and delivering value to all stakeholders Highly Fragmented Market Low Quality Standard Low on Technical Qualifications & Accreditations (99.9% labs remain un-accredited) Non-Compliant: Governance, Legal, Medical No Technology Up-gradation No Customer Service Un-sustainable and un-scalable business model + High Quality Standards with Large Test Menu Customer Convenience Highly Compliant w.r.t Governance, Legal & Medical regulations Sustainable and Scalable Business Model Routine Test Majority Diagnostic Players + Moderate Competition + High Margins in % Semi-Specialized Test Few Focused Players + Intense Competition and Highly Commoditized + Packages and Test Menu is Key Specialized Test Few Players as market demands high accuracy and Quality Parameters + METROPOLIS The Pathology Specialist Metropolis Focus Presence across Value Chain as we are a National Player Focus on High Value added Specialized Test Resulting High Quality Earnings and Profitability Metropolis Test Mix FY22 Total Business Volumes Mix Value Mix Routine 41% 14% Semi Specialized 34% 29% + Specialized 25% 49% High absolute margin but low volumes Wellness 1% 7% 43 Low Competition
View entire presentation